Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TMEM158 |
| Upstream (Parents) |
|---|
| (<<) ADAM19 → TMEM158 |
| (<<) ADAM8 → TMEM158 |
| (<<) ASAM → TMEM158 |
| (<<) BMP2 → TMEM158 |
| (<<) CCNA1 → TMEM158 |
| (<<) CHST2 → TMEM158 |
| (<<) CNIH4 → TMEM158 |
| (<<) COTL1 → TMEM158 |
| (<<) CREB3L4 → TMEM158 |
| (<<) ELF5 → TMEM158 |
| (<<) FA2H → TMEM158 |
| (<<) FGFR2 → TMEM158 |
| (<<) FOSL1 → TMEM158 |
| (<<) FUT4 → TMEM158 |
| (<<) GLS → TMEM158 |
| (<<) GNG11 → TMEM158 |
| (<<) HSD17B2 → TMEM158 |
| (<<) MMP7 → TMEM158 |
| (<<) MRAS → TMEM158 |
| (<<) PHLDA1 → TMEM158 |
| (<<) PRKCDBP → TMEM158 |
| (<<) PRSS2 → TMEM158 |
| (<<) PRSS3 → TMEM158 |
| (<<) RHOV → TMEM158 |
| (<<) SCARB1 → TMEM158 |
| (<<) SOCS3 → TMEM158 |
| (<<) SOX8 → TMEM158 |
| (<<) TCEAL1 → TMEM158 |
| (<<) TMEM45B → TMEM158 |
| (<<) VIM → TMEM158 |
| (<<) YWHAB → TMEM158 |
| Downstream (Children) |
|---|
| TMEM158 → AKT3 (>>) |
| TMEM158 → BCL2A1 (>>) |
| TMEM158 → CDH3 (>>) |
| TMEM158 → CEP170 (>>) |
| TMEM158 → CHSY1 (>>) |
| TMEM158 → CITED4 (>>) |
| TMEM158 → ENO2 (>>) |
| TMEM158 → F2RL1 (>>) |
| TMEM158 → FERMT1 (>>) |
| TMEM158 → GNA15 (>>) |
| TMEM158 → KHDRBS3 (>>) |
| TMEM158 → KRT6B (>>) |
| TMEM158 → LOC650392 (>>) |
| TMEM158 → MMP9 (>>) |
| TMEM158 → NPAS3 (>>) |
| TMEM158 → ORM1 (>>) |
| TMEM158 → PLCB4 (>>) |
| TMEM158 → PLEKHF1 (>>) |
| TMEM158 → PRKCA (>>) |
| TMEM158 → SDK2 (>>) |
| TMEM158 → SLC7A5 (>>) |
| TMEM158 → WNT5A (>>) |
| TMEM158 → WNT5B (>>) |
